Copyright © 2013 American Cancer Society
Edited By: Fadlo R. Khuri, MD
Impact Factor: 4.771
ISI Journal Citation Reports © Ranking: 2011: 36/196 (Oncology)
Online ISSN: 1097-0142
Associated Title(s): Cancer Cytopathology, CA: A Cancer Journal for Clinicians
Current Issue:1 June 2013
Volume 119, Issue 11
1 June 2013
Volume 119, Issue Supplement S11
European-American Dialogues on Cancer Survivorship...
15 May 2013
Volume 119, Issue 10
1 May 2013
Volume 119, Issue 9
15 April 2013
Volume 119, Issue 8
Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma
Diagnostic assays for identification of anaplastic lymphoma kinase-positive non–small cell lung cancer
Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer
Qigong improves quality of life in women undergoing radiotherapy for breast cancer: Results of a randomized controlled trial
I-SPY 2 May Change How Clinical Trials Are Conducted
Researchers aim to accelerate approvals of cancer drugs.
Click here to read this article Click here to download the PDF
European-American Dialogues on Cancer Survivorship: Current Perspectives and Emerging Issues
A Prospective Surveillance Model for Rehabilitation for Women with Breast Cancer
National Patient Navigation Leadership Summit (NPNLS): Measuring the Impact and Potential of Patient Navigation
Adolescents and Young Adults with Cancer: Towards Better Outcomes in Canada
Proceedings of the First International Inflammatory Breast Cancer Conference
Cancer Therapy with Antibodies and Immunoconjugates
Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: Detailed safety analysis from a phase 3 trial in patients with advanced melanoma
Click here to read and download the article for free.
Read the Letter to Cancer Authors from the Editor-in-Chief where Dr. Fadlo Khuri shares the positive developments at Cancer.
Published on behalf of the American Cancer Society
Copyright © 1999–2013 John Wiley & Sons, Inc. All Rights Reserved.